SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models-Reference-Cited by-同舟云学术

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models

Published:2021-03 Issue:4 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Kwon Oh‐Chan¹²³^ORCID,Song Jae‐Jin¹²,Yang Yunseon¹²³,Kim Seong‐Hoon¹²³,Kim Ji Young¹²³,Seok Min‐Jong¹²³,Hwang Inhwa⁴,Yu Je‐Wook⁴^ORCID,Karmacharya Jenisha⁵,Maeng Han‐Joo⁵,Kim Jiyoung⁶,Jho Eek‐hoon⁶^ORCID,Ko Seung Yeon¹²³,Son Hyeon¹²³,Chang Mi‐Yoon¹²,Lee Sang‐Hun¹²³^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology College of Medicine Hanyang University Seoul Korea

2. Hanyang Biomedical Research Institute Hanyang University Seoul Korea

3. Graduate School of Biomedical Science and Engineering Hanyang University Seoul

4. Korea Department of Microbiology and Immunology Institute for Immunology and Immunological Diseases Brain Korea 21 PLUS Project for Medical Science Yonsei University College of Medicine Seoul South Korea

5. College of Pharmacy Gachon University Incheon Korea

6. Department of Life Science University of Seoul Seoul Korea

Funder

National Research Foundation of Korea

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202013076

Reference126 articles.

1. EMD638683, a Novel SGK Inhibitor with Antihypertensive Potency